Recent medical discoveries have made Alzheimer’s disease and dementia easier to identify and manage, but these conditions still have a disproportionate impact on Black communities. Research shows that African Americans are more at risk for developing Alzheimer’s and are less likely to be screened for it. Dr. Doris Molina-Henry works with the Alzheimer’s Therapeutic Research Institute at the University of Southern California. She’s trying to bridge that gap with a new set of clinical trials called the AHEAD study. We talk with her about the study, why Black communities are more at risk for Alzheimer’s, and how diverse participation in clinical trials can help.

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices